Hyperimmune Globulins Market: Future Growth Drivers

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Hyperimmune Globulins Market Between 2026 And 2030?

The hyperimmune globulins market size has experienced significant expansion recently. It is projected to increase from $2.06 billion in 2025 to $2.21 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.6%. This historical growth can be attributed to factors such as established use in rabies and tetanus prophylaxis, increasing incidence of infectious diseases, reliance on plasma-derived therapies, government immunization programs, and the growth of hospital-based emergency care.

The hyperimmune globulins market size is anticipated to experience significant expansion in the coming years, with projections indicating it will reach $2.86 billion in 2030, growing at a compound annual growth rate (CAGR) of 6.7%. This expansion during the forecast period can be attributed to factors such as increasing organ transplantation procedures, a surge in viral infection outbreaks, the development of plasma donation infrastructure, innovations in purification technologies, and a heightened focus on immediate immune protection. Significant trends expected during this period include a rising demand for passive immunization treatments, enhanced utilization in post-exposure prophylaxis, increased adoption within transplant and immunocompromised patient care, an expansion of plasma collection and fractionation capacities, and the fortification of regulatory supervision and quality guidelines.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Which Key Drivers Are Affecting The Hyperimmune Globulins Market Development?

The expanding occurrence of infectious diseases is projected to boost the hyperimmune globulin market in the coming years. These illnesses arise from harmful agents, known as pathogens, including viruses, bacteria, fungi, and parasites, entering the body. The rising incidence of infectious diseases stems from factors such as antimicrobial resistance, climate change, and population growth. Hyperimmune globulins are employed in managing infectious diseases to confer immediate passive immunity, providing concentrated antibodies against specific pathogens to help prevent or treat conditions like rabies, hepatitis B, or tetanus. As an example, in August 2024, a report by the UK Health Security Agency, a UK-based government body, revealed that in 2023, the West Midlands region documented the most measles cases, with 160 cases (44%), with London following at 122 cases (33%). Significantly, children under the age of 10 accounted for 63% of all cases, totaling 232 cases. Measles activity escalated sharply towards the year’s end, with 157 new cases identified in December, contrasting with only 45 cases in November. Consequently, the rising prevalence of infectious diseases is propelling the growth of the hyperimmune globulin market. Government-led research and development efforts in healthcare are anticipated to fuel the expansion of the hyperimmune globulins market. These governmental initiatives are increasing due to the growing need for cutting-edge medical advancements and the imperative to tackle new health issues. Such initiatives aid in the creation and availability of hyperimmune globulins, enabling effective counter-measures against particular infectious diseases. For illustration, in May 2024, the Office for National Statistics, a UK-based government department, stated that overall healthcare expenditure experienced a 5.6% increase in nominal terms from 2022 to 2023, which signifies a notable acceleration compared to the 0.9% growth recorded in 2022. Hence, the escalating government initiatives for research and development in healthcare are boosting the hyperimmune globulins market.

What Are The Different Segment Types In The Hyperimmune Globulins Market Segment Breakdown?

The hyperimmune globulins market covered in this report is segmented –

1) By Type: Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types

2) By Route Of Administration: Intramuscular, Intravenous

3) By Application: Government Institution, Private Sector, Other Applications

Subsegments:

1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin, Intravenous Hepatitis B Hyperimmune Globulin

2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human), Rabies Immune Globulin (Equine)

3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human), Tetanus Immune Globulin (Equine)

4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation, Cmv Immune Globulin For Neonatal Infection

5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis, Vzv Immune Globulin For Immunocompromised Patients

6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children, Rsv Immune Globulin For Adults With Respiratory Conditions

7) By Other Types: Diphtheria Hyperimmune Globulin, Botulism Hyperimmune Globulin, Other Specialized Hyperimmune Globulins

Who Are The Well-Known Companies In The Hyperimmune Globulins Market?

Major companies operating in the hyperimmune globulins market are Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.

Get The Full Hyperimmune Globulins Market Report:

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Which Region Is The Largest In The Hyperimmune Globulins Market?

North America was the largest region in the hyperimmune globulins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hyperimmune Globulins Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Browse Through More Reports Similar to the Global Hyperimmune Globulins Market 2026, By The Business Research Company

Subcutaneous Immunoglobulin Scig Market Report 2026

https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Immunoglobulins Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Mammalian Polyclonal Immunoglobulin G Igg Antibody Market Report 2026

https://www.thebusinessresearchcompany.com/report/mammalian-polyclonal-immunoglobulin-g-igg-antibody-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795